Amid the tragic consequences of COVID-19, life sciences and medtech companies emerged as lights in the darkness. Decades of scientific work and investment seemed to
...The life sciences industry has traditionally been slow to adopt digital technologies, primarily due to regulations that have encouraged a conservative approach to
...Generating high-value data and insights within the framework of GDPR is possible. It requires data science teams with technical, regulatory, and pharmaceutical
...Increasing data volumes as well as increasing data complexity are currently forcing the drug safety industry to look for solutions to reduce case processing costs
...Large segments of the population are at high risk of vitamin deficiencies, and deficiencies can emerge because of certain disease states, therapeutic interventions,
...Find out how a contract packaging company can deliver the expertise and flexibility needed to ship pharmaceuticals internationally. The global pharmaceutical sector
...The past decade has seen a significant shift in the nature of the products being manufactured and sold by the innovative biopharmaceutical (biopharma) industry. The
...The Pharma industry is passing through a turbulent phase, the industry has been witnessing a drastic dip in R&D productivity and revenue streams are under threat
...Aerogen’s vibrating mesh nebuliser technology, available within the Aerogen® Solo, Pro and also the NIVO, has been adopted for use across many areas of the hospital
...